Most Medicare Part D plans and Part C plans that include drug coverage cover rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic encephalopathy (HE).

Rifaximin has already been successfully used in adults with SIBO and IBS. Aim: To assess the SIBO prevalence and symptoms improvement in IBS children after treatment with Rifaximin. Study design ...

Rifaximin is a minimally absorbed antibiotic that is FDA-approved for treatment of travelers' diarrhea and prevention of hepatic encephalopathy. The primary endpoint (patient-reported "adequate ...